Trials / Completed
CompletedNCT00314756
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
Topical Imiquimod 5% Cream in the Treatment of Nodular Basal Cell Carcinoma After Initial Treatment With Curettage
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (planned)
- Sponsor
- Wake Forest University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To assess the efficacy of treating a nodular basal cell carcinoma with imiquimod cream after initial treatment with curettage
Detailed description
The primary objective of this study is to evaluate the efficacy of imiquimod 5% cream on nodular BCC lesions treated 5x/week for 6 weeks after primary treatment with curettage without electrodesiccation. The secondary objective of this study is to evaluate the cosmetic outcome after treatment of the lesions using this modality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | imiquimod |
Timeline
- Start date
- 2005-03-01
- Completion
- 2005-11-01
- First posted
- 2006-04-14
- Last updated
- 2023-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00314756. Inclusion in this directory is not an endorsement.